The State of Global Life-Sciences Innovation Policy

September 12, 2017

In a presentation to a roundtable gathering of international think tanks in New York City, Stephen Ezell argued we are entering an era of renewed biomedical innovation marked by a wide range of new-to-the-world treatments for cancers, rare and chronic diseases, and other disorders. Today, the United States is leading this wave of innovation, but that wasn’t always the case, as Europe led up until 1990. Ezell outlined the key life-sciences innovation policy changes the U.S. has made over the past two decades to achieve life-sciences leadership, and explained how other countries, developed or developing, can take a similar approach to bolster their innovation-based life-sciences sectors.